<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00583817</url>
  </required_header>
  <id_info>
    <org_study_id>G000101</org_study_id>
    <secondary_id>IRB 3917</secondary_id>
    <nct_id>NCT00583817</nct_id>
  </id_info>
  <brief_title>Endovascular Exclusion of Ascending and Thoracic Aortic Pathology</brief_title>
  <official_title>Endovascular Exclusion of Ascending and Thoracic Aortic Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Matthew Eagleton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the role of ascending and/or aortic arch
      aneurysm/dissections treatment using a novel endovascular prosthesis in high risk surgical
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, non-randomized evaluation of ascending and thoracic pathology
      endovascular repair in the high-risk patient. The purpose of this study is to assess the role
      of the thoracic aortic pathology treatment using endovascular prosthesis in high-risk
      patients. The study objectives include (1) to assess the safety and efficacy of endovascular
      prosthesis as a means of preventing aneurysm growth and rupture in high risk patients, (2) to
      measure the physiologic effects and outcomes of endovascular aneurysm repair, (3) to
      establish selection criteria, improve device design, operative technique, and follow-up
      procedures for patients undergoing aneurysm repair. There will be up to 15 patients in the
      ascending aortic lesion arm and 20 patients in Arch Branch arm; all at one site (The
      Cleveland Clinic). Baseline procedures may include an angiogram, intravascular ultrasound, CT
      scan, chest x-ray, physical exam, blood work, and ankle-brachial index. The endovascular
      prosthesis is placed in the operating room under regional or general anesthesia. Follow-up
      evaluations may include physical exam, blood work, CT scan or MRI, chest x-ray, cardiac echo
      and ankle-brachial index.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2001</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from aneurysm rupture</measure>
    <time_frame>2 years</time_frame>
    <description>Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Thoracic Aortic Aneurysms</condition>
  <condition>Dissecting, Aneurysm</condition>
  <condition>Ascending Aorta Aneurysm</condition>
  <condition>Aortic Arch; Aneurysm, Dissecting</condition>
  <condition>Ascending Aortic Dissection</condition>
  <arm_group>
    <arm_group_label>Ascending Aortic Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational endovascular stent-graft implantation to exclude aneurysm or repair dissection of the ascending aorta.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arch Branch Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational endovascular stent-graft implantation to exclude aneurysm or repair dissection of the aortic arch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular stent-graft implantation</intervention_name>
    <description>Endovascular repair with a research device</description>
    <arm_group_label>Ascending Aortic Arm</arm_group_label>
    <arm_group_label>Arch Branch Arm</arm_group_label>
    <other_name>Cook Zenith</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        i)Life expectancy greater than 2 years ii) Suitable arterial anatomy iii) Absence of
        systemic disease or allergy that precludes an endovascular repair iv) Capable of giving
        informed consent and willingness to comply with follow up schedule v) Patient is considered
        high or prohibitive risk for open surgical repair of the ascending aneurysm or dissection

        Exclusion Criteria:

        Patient excluded if ANY of the following are true:

        i) Pregnancy ii) History of anaphylactic reaction to contrast material with an inability to
        properly prophylax the patient appropriately iii) Allergy to stainless steel or polyester
        (allergy to stainless steel is not relevant if the Low Profile device is to be used) iv)
        Unwilling to comply with follow up schedule v) Serious or systemic groin infection vi) An
        uncorrectable coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew J Eagleton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuki Kuramochi, RN, BSN</last_name>
    <phone>216-445-4063</phone>
    <email>kuramoy@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Matthew Eagleton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Roselli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federico E Parodi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2007</study_first_submitted>
  <study_first_submitted_qc>December 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2007</study_first_posted>
  <last_update_submitted>April 12, 2017</last_update_submitted>
  <last_update_submitted_qc>April 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Matthew Eagleton</investigator_full_name>
    <investigator_title>Staff</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

